Centro de Oncologia Mackenzie

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Cervical cancer1 trial
• Gastric and oesophageal cancer1 trial
• Head and neck cancer1 trial
• Liver and biliary tract cancer1 trial
• Lung cancer1 trial
• Ovarian cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 1/21 trial
• Phase 31 trial

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• Amgen2 trials

Closed trials

• Terminated

  A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

  NCT05325866· Phase 1/2· Amgen· Source

• Completed

  Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

  NCT05052801· Phase 3· Amgen· Source